Prime Medicine reverses course to seek FDA approval of shelved therapynews2026-03-03T20:48:13+00:00March 3rd, 2026|Endpoints News|
After years of dispute with FDA, Vanda will get a public hearing for jet lag drugnews2026-03-03T20:21:28+00:00March 3rd, 2026|Endpoints News|
FDA explains how some copycat drugs can still win three years of exclusivitynews2026-03-03T18:39:48+00:00March 3rd, 2026|Endpoints News|
Two more members added to ACIP ahead of March meetingnews2026-03-02T20:35:20+00:00March 2nd, 2026|Endpoints News|
FDA lifts hold on second Intellia Phase 3 gene editing trialnews2026-03-02T15:23:14+00:00March 2nd, 2026|Endpoints News|
UniQure says FDA prefers randomized trial for Huntington’s treatmentnews2026-03-02T12:35:27+00:00March 2nd, 2026|Endpoints News|
Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvimanews2026-02-28T15:00:54+00:00February 28th, 2026|Endpoints News|
Ascendis wins FDA approval for achondroplasia drug, waits on EU actionnews2026-02-27T22:52:42+00:00February 27th, 2026|Endpoints News|
Synergy Spine Solutions Earns FDA Approval for the Synergy Disc, Advancing Cervical Disc Replacement in the U.S.news2026-02-27T14:36:07+00:00February 27th, 2026|Medical Device News Magazine|
FDA probes internal Prasad complaints with outside helpnews2026-02-26T20:13:02+00:00February 26th, 2026|Endpoints News|
